Relaxation method studied to ease anxiety in brain tumor patients

NCT ID NCT05189366

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 26 times

Summary

This study tested whether adding sophrology—a relaxation technique using hypnosis, meditation, and breathing exercises—to standard speech therapy could help reduce anxiety and improve quality of life in people with aggressive brain tumors (glial tumors). The trial planned to enroll 13 patients but was terminated early. Researchers hoped the combination would address the high anxiety and depression common in this group, especially when communication is difficult.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIAL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Institut de Cancérologie de l'Ouest

    Saint-Herblain, 44805, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Sophrology (a relaxation method using hypnosis, visualization, meditation, and breathing exercises)

What this could lead to

If it worked, this approach could offer a simple, drug-free way to reduce anxiety and improve quality of life for brain tumor patients with communication difficulties.

What could go wrong

The trial was terminated early with only 13 participants, so results are very limited. It is unclear if sophrology provides any real benefit over speech therapy alone.

Conditions

The condition(s) this trial relates to.

communication disorder glioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.